Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase I, open-label, multi-centre study designed to assess the safety and
tolerability of Cediranib in combination with lomustine in patients with primary recurrent
malignant brain tumour.